HURA
TuHURA Biosciences, Inc.
1W: -9.1%
1M: +17.8%
3M: +127.1%
YTD: +138.8%
1Y: -49.3%
3Y: -51.4%
5Y: -98.1%
$1.41
-0.21 (-12.96%)
After Hours: $1.44 (+0.03, +2.48%)
Weekly Expected Move ±14.9%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$79.6M
52W Range0.41-4.44
Volume1,210,012
Avg Volume1,654,519
Beta-0.31
Dividend—
Analyst Ratings
Company Info
CEOJames A. Bianco
Employees19
SectorHealthcare
IndustryBiotechnology
IPO Date2013-02-22
Websitetuhurabio.com
10500 University Center Drive
Tampa
US
Tampa
US
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Latest News
TuHURA Biosciences reports FY results
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
TuHURA Biosciences (NASDAQ:HURA) Trading Down 3.1% – Here’s Why
TuHURA Biosciences Announces Participation in Upcoming Investor Conferences
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Hoffman Robert E. | A-Award | 156,240 | $1.29 | 2026-02-12 |
| Tendler Craig | A-Award | 156,240 | $1.29 | 2026-02-12 |
| Ng George K | A-Award | 156,240 | $1.29 | 2026-02-12 |
| MANUSO JAMES S J | A-Award | 156,240 | $1.29 | 2026-02-12 |
| List Alan | A-Award | 156,240 | $1.29 | 2026-02-12 |